Healthpeak Properties, Inc. logo

Healthpeak Properties, Inc.

DOC

NYSEReal EstateREIT - Healthcare Facilities

Previous close

$21.40

+$0.20 · +0.94%

Aug 21, 4:00 PM ET

DOC company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Buy

Favorable setup — positive multi-factor alignment

Valuation

68

Undervalued

Momentum

61

Gaining

Sentiment

50

Mixed

Risk resilience

78

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Healthpeak Properties, Inc. is an S&P 500 constituent operating as a fully integrated real estate investment trust (REIT). The firm is dedicated to the acquisition, management, and development of premier properties essential for both medical research and the provision of healthcare services.

Industry
REIT - Healthcare Facilities
Sector
Real Estate
Headquarters
US
CEO
Scott Brinker
Listed since
May 23, 1985
Employees
411

Market position

Day range

Current $21.40

52-week range

Current $21.40

Open
$21.325
Previous close
$21.20
Volume
3.97M
0.52× average
Average volume
7.7M
Average daily volume
Market cap
14.75B USD
Beta
0.99
Market reference 1
50-day average
$21.38
+0.09% above average
200-day average
$18.4368
+16.07% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM)
61.14×
P/B (TTM)
1.88×
P/S (TTM)
Dividend yield
5.70%

Profitability & efficiency

Gross margin
2.53%
Operating margin
17.61%
Net margin
8.60%

Financial health

Debt / equity
1.32×
Altman Z-score
1.03
Piotroski F-score
7 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends66%43%20%-3%Gross margin, FY2021: 59.22%Gross margin, FY2022: 58.13%Gross margin, FY2023: 58.64%Gross margin, FY2024: 60.20%Gross margin, FY2025: 22.48%Operating margin, FY2021: 17.95%Operating margin, FY2022: 17.30%Operating margin, FY2023: 19.89%Operating margin, FY2024: 17.45%Operating margin, FY2025: 19.28%Net margin, FY2021: 26.66%Net margin, FY2022: 24.28%Net margin, FY2023: 14.03%Net margin, FY2024: 9.00%Net margin, FY2025: 2.53%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 59.22%. Gross margin FY2022 58.13%. Gross margin FY2023 58.64%. Gross margin FY2024 60.20%. Gross margin FY2025 22.48%. Operating margin FY2021 17.95%. Operating margin FY2022 17.30%. Operating margin FY2023 19.89%. Operating margin FY2024 17.45%. Operating margin FY2025 19.28%. Net margin FY2021 26.66%. Net margin FY2022 24.28%. Net margin FY2023 14.03%. Net margin FY2024 9.00%. Net margin FY2025 2.53%.

Income trends

Revenue

2.82B USD+4.52%

Operating income

544.13M USD+15.47%

Net income

71.35M USD-70.66%
Income trends across reported periods3.1B USD2B USD896.7M USD−203.77M USDRevenue, FY2021: 1.9B USDRevenue, FY2022: 2.06B USDRevenue, FY2023: 2.18B USDRevenue, FY2024: 2.7B USDRevenue, FY2025: 2.82B USDOperating income, FY2021: 340.32M USDOperating income, FY2022: 356.59M USDOperating income, FY2023: 433.91M USDOperating income, FY2024: 471.22M USDOperating income, FY2025: 544.13M USDNet income, FY2021: 505.54M USDNet income, FY2022: 500.45M USDNet income, FY2023: 306.01M USDNet income, FY2024: 243.14M USDNet income, FY2025: 71.35M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 1.9B USD. Revenue FY2022 2.06B USD. Revenue FY2023 2.18B USD. Revenue FY2024 2.7B USD. Revenue FY2025 2.82B USD. Operating income FY2021 340.32M USD. Operating income FY2022 356.59M USD. Operating income FY2023 433.91M USD. Operating income FY2024 471.22M USD. Operating income FY2025 544.13M USD. Net income FY2021 505.54M USD. Net income FY2022 500.45M USD. Net income FY2023 306.01M USD. Net income FY2024 243.14M USD. Net income FY2025 71.35M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue2.82B USD2.7B USD2.18B USD2.06B USD1.9B USD
Cost of goods sold2.19B USD1.07B USD902.06M USD862.99M USD773.28M USD
Gross profit634.55M USD1.63B USD1.28B USD1.2B USD1.12B USD
Selling, general, and administrative90.42M USD97.16M USD95.13M USD131.03M USD98.3M USD
Operating expenses90.42M USD1.15B USD845.03M USD841.6M USD782.59M USD
Interest expense305.18M USD280.43M USD200.33M USD172.94M USD157.98M USD
Depreciation and amortization1.06B USD1.06B USD749.9M USD710.57M USD684.29M USD
Operating income544.13M USD471.22M USD433.91M USD356.59M USD340.32M USD
Net income71.35M USD243.14M USD306.01M USD500.45M USD505.54M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
55%
6 beats, 5 misses, 0 met estimates
Average EPS surprise
+16.66%
11 comparable reports
Latest EPS result
0.08
Estimate 0.03 · Beat by 184.19%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.50.260.02-0.22Q1 '25MissQ2 '25BeatQ3 '25MissQ4 '25MissQ1 '26MissQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 3, 2025: actual 0.01, estimate 0.05, surprise -80.00%, Miss. Q2 2025, reported Apr 24, 2025: actual 0.061, estimate 0.054, surprise +11.71%, Beat. Q3 2025, reported Jul 24, 2025: actual 0.05, estimate 0.064, surprise -21.86%, Miss. Q4 2025, reported Oct 23, 2025: actual -0.17, estimate 0.06, surprise -383.33%, Miss. Q1 2026, reported Feb 2, 2026: actual 0.16, estimate 0.45, surprise -64.44%, Miss. Q2 2026, reported May 5, 2026: actual 0.28, estimate 0.053, surprise +430.71%, Beat. Q3 2026, reported Aug 4, 2026: actual 0.08, estimate 0.028, surprise +184.19%, Beat. Q4 2026, reported Oct 22, 2026: actual —, estimate 0.056, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates779.8M736.05M692.3M648.55MQ1 '25BeatQ2 '25BeatQ3 '25MissQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 3, 2025: actual 697.99M USD, estimate 688.87M USD, surprise +1.32%, Beat. Q2 2025, reported Apr 24, 2025: actual 702.89M USD, estimate 683.23M USD, surprise +2.88%, Beat. Q3 2025, reported Jul 24, 2025: actual 678.54M USD, estimate 689.32M USD, surprise -1.56%, Miss. Q4 2025, reported Oct 23, 2025: actual 690.34M USD, estimate 686.88M USD, surprise +0.50%, Beat. Q1 2026, reported Feb 2, 2026: actual 704.78M USD, estimate 691.65M USD, surprise +1.90%, Beat. Q2 2026, reported May 5, 2026: actual 738.78M USD, estimate 694.59M USD, surprise +6.36%, Beat. Q3 2026, reported Aug 4, 2026: actual 749.81M USD, estimate 725.64M USD, surprise +3.33%, Beat. Q4 2026, reported Oct 22, 2026: actual —, estimate 740.3M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$22.25

3.97% upside
Past 12 months12-month forecastHigh $24.00Average $22.25Low $19.00

Recent analyst actions

12 institutions
Cantor FitzgeraldmaintainNeutral
BarclaysdowngradeOverweightEqual Weight

DOC news

Corporate actions

Corporate action history

Stock split

Effective Nov 1, 2016

549:500

Stock split

Effective Mar 2, 2004

2:1

Stock split

Effective May 21, 1992

2:1

DOC peers

ETFs holding DOC

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research DOC

research.disclaimer